Ben M. Dunn
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
Papers in
- Virology 42
- HIV Research and Treatment 42
-
- Enzyme Production and Characterization 30
- Co-authors
- John KayIrwin ChaikenAlexander WlodawerAlla GustchinaLowri H. PhylipMaureen M. GoodenowMichael W. PenningtonAnthony D. Richards
- Journals
- Biochemistry (25 papers)Advances in experimental medicine and biology (21 papers)Journal of Biological Chemistry (11 papers)Current Protocols in Protein Science (10 papers)FEBS Letters (10 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Ben M. Dunn
212 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 135
- Virology 1.4k
- Infectious Diseases 1.7k
- Biotechnology 650
- Molecular Biology 3.4k
- Oncology 869
Countries citing papers authored by Ben M. Dunn
This map shows the geographic impact of Ben M. Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben M. Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben M. Dunn more than expected).
Fields of papers citing papers by Ben M. Dunn
This network shows the impact of papers produced by Ben M. Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben M. Dunn. The network helps show where Ben M. Dunn may publish in the future.
Co-authors
The 25 scholars most cited alongside Ben M. Dunn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hearing “moon” and looking up: Word-related spatial associations facilitate saccades to congruent locations | 2014 | 7 |
| 2 | 2012 | 24 | |
| 3 | 2010 | 24 | |
| 4 | 2009 | 2 | |
| 5 | 2008 | 17 | |
| 6 | 2006 | 40 | |
| 7 | 1998 | 25 | |
| 8 | 1995 | 1 | |
| 9 | 1995 | 19 | |
| 10 | 1995 | 5 | |
| 11 | 1995 | 3 | |
| 12 | 1994 | 97 | |
| 13 | 1992 | 21 | |
| 14 | 1992 | 22 | |
| 15 | 1991 | 3 | |
| 16 | 1989 | 39 | |
| 17 | 1989 | 23 | |
| 18 | Unconventional amino acid sequence of the sun anemone (Stoichactis helianthus) polypeptide neurotoxin | 1986 | 1 |
| 19 | 1985 | 26 | |
| 20 | 1985 | 31 |
About Ben M. Dunn
Ben M. Dunn is a scholar working on Virology, Biotechnology, Infectious Diseases, Molecular Biology and Oncology, having authored 214 papers that have together received 6.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (52 papers), HIV Research and Treatment (42 papers), Peptidase Inhibition and Analysis (32 papers), Biochemical and Structural Characterization (30 papers), Enzyme Production and Characterization (30 papers), Chemical Synthesis and Analysis (27 papers), Malaria Research and Control (25 papers) and Protein Hydrolysis and Bioactive Peptides (19 papers). The work is most often cited by research in Virology (1.4k citations), Infectious Diseases (1.7k citations), Biotechnology (650 citations), Molecular Biology (3.4k citations) and Oncology (869 citations). Ben M. Dunn has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include John Kay, Irwin Chaiken, Alexander Wlodawer, Alla Gustchina, John Kay, Lowri H. Phylip, Maureen M. Goodenow, Michael W. Pennington, Anthony D. Richards and Paula E. Scarborough. Their work appears in journals such as Biochemistry, Advances in experimental medicine and biology, Journal of Biological Chemistry, Current Protocols in Protein Science and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.